Venture Capital

Interview: 4-Antibody AG - How do you structure a biotech for divestment?

Friday 27 April 2012

Interviewee/Contributer: Robert Burns

Organisation: 4-Antibody AG

Full text available to subscribers only. Click here for information on subscribing to MedNous.

The role of technology providers in biotech

Friday 24 February 2012

Interviewee/Contributer: John Burt

Organisation: PolyTherics

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Investment pendulum swings back towards biotech

Friday 20 January 2012

Interviewee/Contributer: Bart Bergstein

Organisation: Forbion Capital Partners

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Shire Plc adds new dimension to its strategy

Saturday 10 September 2011

Interviewee/Contributer: Gwen Melincoff

Organisation: Shire Plc

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Shortage of risk capital keeps befuddling markets

Sunday 10 April 2011

Interviewee/Contributer: 

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Capital efficiency -- a new norm

Tuesday 22 March 2011

Interviewee/Contributer: Werner Lanthaler

Organisation: Evotec AG

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Launch of Takeda Ventures

Monday 10 January 2011

Interviewee/Contributer: Graeme Martin

Organisation: Takeda Ventures

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Boehringer Ingelheim opts for nimble approach

Thursday 23 September 2010

Interviewee/Contributer: Ilka Wicke

Organisation: Boehringer Ingelheim Venture Fund GmbH

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Corporate venture capital shifts to a higher gear

Saturday 15 May 2010

Interviewee/Contributer: William Ellington

Organisation: MedNous

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Getting in the loop with Bicycle Therapeutics

Tuesday 10 November 2009

Interviewee/Contributer: Regina Hodits

Organisation: Atlas Venture

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content